COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1811: Articles 18101-18110  | Next

D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Viral Transmission via Enhanced Furin-mediated Spike Cleavage
Cheng, Y.-W., Chao, T.-L., Li, C.-L., Wang, S.-H., Kao, H.-C., Tsai, Y.-M., Wang, H.-Y., Hsieh, C.-L., Chen, P.-J., Chang, S.-Y., Yeh, S.-H.
10.1101/2021.01.27.428541 — Posted: 2021-01-28
Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein
DiMuzio, J. M., Heimbach, B. C., Howanski, R. J., Dowling, J. P., Patel, N. B., Henriquez, N., Nicolescu, C., Nath, M., Polley, A., Bingaman, J. L., Smith, T., Harman, B. C., Robinson, M. K., Morin, M. J., Nikitin, P. A.
10.1101/2021.01.27.428534 — Posted: 2021-01-28
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines
Shen, X., Tang, H., McDana, C., Wagh, K., Fischer, W., Theiler, J., Yoon, H., Haynes, B. F., Saunders, K. O., Gnanakaran, S., Hengartner, N. W., Pajon, R., Smith, G., Dubovsky, F., Glenn, G. M., Korber, B., Montefiori, D.
10.1101/2021.01.27.428516 — Posted: 2021-01-28
Genome-scale metabolic modeling reveals SARS-CoV-2-induced host metabolic reprogramming and identifies metabolic antiviral targets
Cheng, K., Riva, L., Sinha, S., Pal, L. R., Nair, N. U., Martin-Sancho, L., Chanda, S. K., Ruppin, E.
10.1101/2021.01.27.428543 — Posted: 2021-01-28
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
Neidleman, J., Luo, X., George, A. F., McGregor, M., Yang, J., Yun, C., Murray, V., Gill, G., Greene, W. C., Vasquez, J., Lee, S., Ghosn, E., Lynch, K., Roan, N. R.
10.1101/2021.01.22.21250054 — Posted: 2021-01-28
Trajectories of Hypoxemia & Respiratory System Mechanics of COVID-19 ARDS in the NorthCARDS dataset
Jafari, D., Gandomi-Sereshki, A., Makhnevich, A., Qiu, M., Rolston, D. M., Gottesman, E. P., Tsegaye, A., Mayo, P. H., Stewart, M. E., Zhang, M., Hajizadeh, N.
10.1101/2021.01.26.21250492 — Posted: 2021-01-28
Immune response to SARS-CoV-2 in the nasal mucosa in children and adults
Koch, C. M., Prigge, A. D., Anekalla, K. R., Shukla, A., Chi Do-Umehara, H., Setar, L., Chavez, J., Abdala-Valencia, H., Politanska, Y., Markov, N. S., Hahn, G. R., Heald-Sargent, T., Sanchez-Pinto, L. N., Muller, W. J., Misharin, A. V., Ridge, K. M., Coates, B. M.
10.1101/2021.01.26.21250269 — Posted: 2021-01-28
Individual factors underlie temperature variation in sickness and in health: influence of age, BMI and genetic factors in a multi-cohort study
Penfold, R. S., Zazzara, M. B., Österdahl, M. F., GSTT CovidCollaborative, , Welch, C., Ni Lochlainn, M., Freidin, M., Bowyer, R. C. E., Thompson, E. E. J., Antonelli, M., Tan, Y. X. R., Sudre, C., Modat, M., Murray, B., Wolf, J., Ourselin, S., Veenith, T., Lord, J. M., Steves, C. J.
10.1101/2021.01.26.21250480 — Posted: 2021-01-28
The angiotensin type 2 receptor agonist C21 restores respiratory function in COVID19 - a double-blind, randomized, placebo-controlled Phase 2 trial
Tornling, G., Batta, R., Porter, J., Bengtsson, T., Parmar, K., Kashiva, R., Cohrt, A. K., Westergaard, K., Hallberg, A., Dalsgaard, C.-J., Raud, J.
10.1101/2021.01.26.21250511 — Posted: 2021-01-28
Do examinations prepare students for higher education? A lesson from the Covid-19 lockdown.
Jones, H. L., Zini, V., Green, J. R., Prendergast, J. R., Scott, J.
10.1101/2021.01.26.428208 — Posted: 2021-01-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).